@article{52aa680d46694f6cb64f0b2558580445,
title = "Chip-AML22 Master Protocol: An Open-Label Clinical Trial in Newly Diagnosed Pediatric De Novo Acute Myeloid Leukemia (AML) Patients Including a Linked Phase II Trial with Quizartinib in FLT3-ITD/ NPM1wt Patients - a Study By the NOPHO-DB-SHIP Consortium",
author = "Kaspers, {Gertjan J.L.} and Wijnen, {Noa E.} and Koedijk, {Joost B.} and Sae Ishimaru and Renske Benedictus and {Van Opstal}, {Ellen C.} and {Van Tinteren}, Harm and Zwaan, {C. Michel} and Noha Biserna and Pamela Downs and Yvonne Duong and Kamel, {Yasser Mostafa} and Jonas Abrahamsson and Nira Arad-Cohen and Nicole Bodmer and Luis Castillo and Daniel Cheuk and Vitor Costa and {De Moerloose}, Barbara and {Fernandez Navarro}, {Jose Maria} and Linda Fogelstrand and Goemans, {Bianca F.} and Henrik Hasle and Jonsson, {Olafur G.} and Zhanna Kovalova and Munthe-Kaas, {Monica C.} and Ulrika Nor{\'e}n-Nystr{\"o}m and Sauli Palmu and Ramune Pasauliene and Kadri Saks and Tierens, {Anne Maria} and Dominik Turkiewicz and Pronk, {Cornelis Jan}",
year = "2023",
month = nov,
day = "28",
doi = "10.1182/blood-2023-181792",
language = "English",
volume = "142",
journal = "Blood",
issn = "0006-4971",
publisher = "Elsevier B.V.",
number = "Suppl.1",
note = "ASH Annual Meeting, ASH ; Conference date: 09-12-2023 Through 12-12-2023",
url = "https://www.hematology.org/newsroom/annual-meeting-press/press-kit/general-annual-meeting-information-and-materials",
}